Stephan Grabbe
Johannes Gutenberg University Mainz · 976 works · 29,668 citations · h-index 71
Top works
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- Antigen Presentation in Extracellular Matrix
- Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity
- Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide
- Influence of pH on wound-healing: a new perspective for wound-therapy?
- Tumor antigen presentation by murine epidermal cells
- Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation Stage
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
- Spontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice
- IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
- Interaction of Dendritic Cells with Skin Endothelium: A New Perspective on Immunosurveillance
- Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
- New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma
- High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial